Healthcare distribution giant Cencora (NYSE: COR) reported quarterly revenue that missed Wall Street expectations, though sales increased 5.5% year-over-year to $85.93 billion. Adjusted earnings per share of $4.08 slightly surpassed consensus estimates.
A sharp decline in Actuate Therapeutics' market valuation last week has disproportionately impacted its major private equity shareholders, who control a dominant stake in the biopharmaceutical firm. The stock's recent performance puts a spotlight on ownership structure and its influence on risk.
The U.S. Justice Department and state coalition challenge a federal judge's ruling, arguing the imposed restrictions on Google's search dominance do not go far enough to restore competition.
A significant shift is underway in the U.S. housing landscape. As inventory grows and demand moderates, homebuyers in key metropolitan areas are finding renewed negotiating power and more choices, according to a new analysis.
Nvidia's pivotal role in powering the artificial intelligence revolution has sent its stock soaring, but with a premium valuation, investors are questioning if the rally still has room to run ahead of its upcoming earnings.
As Ethereum's price plunges to $2,273, treasury firm Bitmine faces massive unrealized losses on its 3.7 million ETH holdings, triggering a decline in its BMNR stock. Chairman Tom Lee attributes the drawdown to broad market weakness and reaffirms the company's long-term accumulation strategy.
In a move to reduce Western reliance on Chinese processing, REAlloys has secured a pivotal 10-year agreement with Kazakhstan's AltynGroup. The deal aims to funnel Central Asian rare earths directly into North American manufacturing, creating a new supply chain for critical defense and tech metals.
A new survey from Goldman Sachs Asset Management reveals a stark retirement readiness gap, with workers enrolled in 401(k) plans accumulating significantly larger nest eggs than their non-participating peers.
Walmart breaches the $1 trillion market cap, becoming the first traditional company to join the elite club. Its aggressive digital transformation and AI investments have not only reshaped the retail landscape but also added $50 billion to the Walton family fortune this year alone, raising questions about wealth, legacy, and the future of work.
Boston Scientific (NYSE:BSX) reported fourth-quarter revenue of $5.29 billion, aligning with Wall Street forecasts and marking a 15.9% year-over-year increase. The medical device giant also posted adjusted earnings of $0.80 per share, slightly above consensus, while providing guidance in line with expectations for the coming quarter.
Buoyed by resilient holiday sales, particularly in the United States, Watches of Switzerland Group has upgraded its full-year sales and profit guidance, highlighting sustained demand for luxury timepieces that continues to outpace supply.
Former Amazon logistics chief Dave Clark and his wife Leigh Anne are steering their AI startup, Auger, through the turbulent world of global trade. In an exclusive interview, they reveal how their partnership—both marital and professional—aims to solve the industry's most persistent headaches.
The Department of Justice is under fire for its handling of the court-ordered release of documents related to Jeffrey Epstein, with critics pointing to significant delays, improper redactions that exposed victims' identities, and the publication of explicit images. Officials defend the process as legally compliant.
While U.S. officials host a global summit on critical minerals, communities in the Democratic Republic of the Congo voice deep skepticism that new deals will translate into local benefits, amid fears of entrenched exploitation and conflict.
Following a major insurgent assault, Pakistani forces have mobilized helicopters and drones in a decisive operation to retake control of a strategic town in restive Balochistan, amid a surge in violence that has claimed hundreds of lives.
The Duke of York has reportedly vacated his long-time Windsor home as newly unsealed court documents fuel fresh allegations concerning his association with the late financier Jeffrey Epstein, placing the royal family under intensified public pressure.
A temporary spending bill ends a brief government shutdown, while a would-be assassin of former President Trump faces sentencing. Other headlines include murder charges for Jill Biden's ex-husband, renewed US-Iran nuclear talks, and a sharp decline in Bitcoin's value.
While the biosimulation leader reports rising revenues and capital investment, its key profitability metric—Return on Capital Employed—has declined to 2.2%, significantly trailing the healthcare services sector. Analysts question whether current growth investments will translate into future shareholder value.
Despite headwinds in the smartphone market, Bernstein remains constructive on Qualcomm (QCOM), citing its valuation discount, high-end market positioning, and growing AI narrative as key drivers for future performance.
While Veeva Systems continues to invest heavily in its future, a five-year slide in its return on capital employed (ROCE) signals potential headwinds for the life sciences cloud giant. We examine whether the current growth-at-all-costs strategy will pay off for long-term shareholders.
